© 2023 MJH Life Sciences and Drug Topics. All rights reserved.
© 2023 MJH Life Sciences™ and Drug Topics. All rights reserved.
Lauren Biscaldi is the Managing Editor of Drug Topics.
January 31, 2023
Adalimumab-atto was first approved by the FDA in 2016.
January 27, 2023
Recommendations from the unanimous vote must be adopted by the FDA and CDC.
January 26, 2023
Investigators analyzed the proportion of individuals with 1 of 3 clusters of Long COVID symptoms.
January 23, 2023
The new medication reduces HbA1c and improves glycemic control as an adjunct to diet and exercise.
January 20, 2023
New legislation removes what many perceived as a barrier to treating opioid use disorder.
The PDUFA date has been set for May 22, 2023.